Vaccine Response Eczema Study- Ages 12 and up

  • STATUS
    Recruiting
Updated on 23 November 2020

Summary

For many people living with moderate- to- severe eczema (also called atopic dermatitis or AD), the treatment options currently available do not provide satisfactory relief from itching or other symptoms.

Researchers have been studying an investigational drug called nemolizumab to find out if it is both safe and beneficial in treating eczema.

In this study, researchers also want to find out if treatment with nemolizumab affects the way the body's immune system responds to vaccines.

 

Description

This study will last up to 28 weeks (approximately 7 months) including a 2- to 4-week screening period, a 16-week treatment period, and an 8-week follow-up period. Participants do not have to pay for the investigational drug, vaccines, study supplies, study visits, or tests that are part of the study.

Details
Condition Eczema (Atopic Dermatitis)
Clinical Study IdentifierTX249671
Last Modified on23 November 2020

Eligibility

Yes No Not Sure

Inclusion Criteria

Is your age between 12 yrs and 54 yrs?
Gender: Male or Female
Do you have Eczema (Atopic Dermatitis)?
To be eligible for this study, you (or your child) must
Be 12 to 54 years of age
Have had moderate-to-severe eczema and itching for at least 2 years
Continue to have itching and other eczema symptoms even while using topical treatments NOT have received any of the following
Any vaccine (except the inactivated flu vaccine) within the past 12 weeks
A meningococcal vaccine within the past year
A Tdap vaccine within the past 5 years
This is not a complete list of study requirements
The study doctor will review the full requirements for this study with you (and your child, if you are the parent/guardian of a possible study participant)
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note